SuperGen to Present at UBS Life Sciences Conference at New Time of 8:30 am Eastern September 23rd
DUBLIN, Calif.-(Business Wire)-September 22, 2009 - SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, and Michael McCullar, Ph.D., Vice President of Strategy and Discovery Operations, will present at the UBS Global Life Sciences Conference in New York at a new time of 8:30 am ET on Wednesday September 23, 2009.
A live webcast of the presentation will be available in the investor relations section of the Company's website at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
